WHOOP Raises $575 Million in Bid to Expand in Europe, Asia, Latin America

WHOOP is a half-billion dollars in the black.

The company has raised $575 million in Series G funding at a $10.1 billion valuation to advance its global expansion and long-term vision for personalized health. Proceeds from the Series G financing will fuel further U.S. growth and international expansion across Europe, the GCC (Gulf Cooperation Council), Latin America, and Asia.

Led by Collaborative Fund, the funding round also included financial support from 2PointZero Group, Qatar Investment Authority (QIA), Mubadala Investment Company, Abbott, Mayo Clinic, Macquarie Capital (entities administered by Macquarie Capital), Glade Brook, B-Flexion, IVP, Foundry, Accomplice, Affinity Partners, Promus Ventures, and Bullhound Capital as well as some prominent global athletes and individual investors. Among the individual investors were Cristiano Ronaldo, LeBron James, Rory McIlroy, Reggie Miller, Niall Horan, Karen Wazen, Virgil van Dijk, Mathieu van der Poel, and Shane Lowry.

This funding occurs at a defining moment for WHOOP and healthcare’s future, company executives claim. Chronic disease is rising globally, while many healthcare systems remain built for reactive care. Concurrently, advances in artificial intelligence (AI) and continuous biometric data are enabling a fundamentally new approach that predicts risk, guides behavior, and improves health in real time. With this investment, WHOOP will accelerate global expansion and scale its platform as a new standard for personalized, preventive health.

“Our raise brings together the world’s most sophisticated investors, leading health institutions, and iconic global athletes behind the mission to unlock human performance and healthspan,” WHOOP Founder/CEO Will Ahmed said. “We are building the personal health platform that people use to improve their health and livelihood.”

WHOOP is experiencing rapid global momentum amid its growth:

• The company now boasts more than 2.5 million members globally
• Bookings grew 103% annually in 2025, exiting the year at a $1.1 billion run rate
• WHOOP operated cash flow positive in 2025
• WHOOP is hiring for more than 600 new roles worldwide this year to support research and development and international expansion

The latest financing will help WHOOP expedite its construction of a personal health platform—i.e., an intelligent, unified system designed to extend the human healthspan, optimize performance, and prevent disease before it begins.

As a strategic investor with a portfolio spanning diagnostics, medical devices, nutrition, and generic medicines, Abbott brings to WHOOP deep healthcare expertise, scale, and a track record of health tech innovation, creating solutions that are more responsive, connected, and personalized. WHOOP and Abbott strive to empower people to take control of their health.

Powered by more than 24 billion hours of physiological data and purpose-built AI models, WHOOP delivers predictive, personalized health insights. Members open the app an average of more than eight times daily—almost three times higher than other screenless wearables—to understand sleep patterns, recovery, and the ways daily behaviors like training, nutrition, and stress impact their overall performance and long-term health. These insights extend beyond sleep and fitness, helping members identify early warning signs, reduce risk, and take action that can prevent serious health events.

“WHOOP has become one of the most important tools I use to support my long-term health,” said Ronaldo, a WHOOP investor and global ambassador. “I am proud to participate in this round because I believe in the future we are building together. No other company has created a health platform this powerful that people are proud to wear.”

WHOOP delivers a wearable membership to help people live healthier, longer lives and unlock their potential. Through a 24/7 wearable with a 14-day battery life, WHOOP provides intelligent health guidance across sleep, recovery, strain, fitness, and longevity. The health platform includes a U.S. Food and Drug Administration-cleared ECG, a Healthspan longevity feature, Blood Pressure Insights, and Advanced Labs blood biomarker analysis. Research shows that people who wear WHOOP daily log more than 90 additional minutes of exercise per week, sleep an additional two hours, and have 10% higher heart rate variability. WHOOP was founded in 2012 and is headquartered in Boston. The company has raised more than $900 million in venture capital, ships to 56 countries, and operates in six languages.